Tenon Medical Inc (TNON) is not a strong buy for a beginner investor with a long-term strategy at this time. Despite some positive financial growth trends, the stock's technical indicators, lack of trading signals, and absence of strong catalysts suggest a neutral position is more appropriate.
The MACD is slightly positive and expanding, but RSI is neutral at 48.646, indicating no clear momentum. Moving averages are bearish, with SMA_200 > SMA_20 > SMA_5. The stock is trading near its pivot level of 0.726, with resistance at 0.771 and support at 0.682. Overall, the technical setup does not indicate a strong buy opportunity.
Revenue increased by 32.24% YoY in Q3 2025, and gross margin improved significantly by 39.83% YoY to 65.9%.
No recent news or significant trading trends from insiders or hedge funds. Stock trend analysis suggests a potential decline of -3.05% in the next week.
In Q3 2025, revenue grew by 32.24% YoY to $1,173,000, and gross margin improved to 65.9%. However, the company remains unprofitable, with a net income of -$3,339,000 and a significant EPS decline of -88.98% YoY.
No analyst rating or price target changes available for this stock.